Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
0.8570
+0.0072 (0.85%)
At close: Aug 7, 2025, 4:00 PM
0.8382
-0.0188 (-2.19%)
Pre-market: Aug 8, 2025, 8:00 AM EDT
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $48.39 million as of August 8, 2025. Its market cap has decreased by -85.70% in one year.
Market Cap
48.39M
Enterprise Value
-32.77M
1-Year Change
-85.70%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $48.39M, a decrease of -94.00%. That is a compound annual growth rate of -43.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 48.39M | -31.04% |
| Dec 31, 2024 | 70.17M | -73.80% |
| Dec 29, 2023 | 267.79M | -6.83% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | 3.03B | 276.02% |
| Sep 25, 2020 | 806.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 575.32B |
| Johnson & Johnson | 413.10B |
| AbbVie | 351.30B |
| Abbott Laboratories | 229.85B |
| AstraZeneca | 227.78B |
| Novartis AG | 223.01B |
| UnitedHealth Group | 221.95B |
| Novo Nordisk | 213.92B |